Drug Profile
Research programme: rabies vaccine - Medicago
Alternative Names: Rabies VLP vaccine - MedicagoLatest Information Update: 03 Mar 2023
Price :
$50
*
At a glance
- Originator Medicago
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rabies
Most Recent Events
- 23 Feb 2023 Discontinued - Preclinical for Rabies in Canada (unspecified route) (Medicago pipeline, February 2023)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Rabies in Canada
- 18 Sep 2013 Medicago has been acquired by Mitsubishi Tanabe Pharma Corporation